Nektar presents early biomarker data for eczema drug at EADV 2026 StreetInsider Source link
Early Response to Ivarmacitinib Predicts Durable Outcomes in Atopic Dermatitis Dermatology Advisor Source link
Childhood Atopic Dermatitis Not Linked to Cardiovascular Risk in Early Adulthood The American Journal of Managed Care® (AJMC®) Source link
New Data Show Early and Consistent Response to VTAMA® (tapinarof) Cream, 1%, in Children Aged 2+ with Atopic Dermatitis, Including Those With Associated Comorbidities The Globe and Mail Source link